VINCERA PHARMA INC
*W EXP 12/24/202 · CUSIP 92731L114
0
institutional holders
-18 vs Q1 2021
—reported value*
0 new
0 added
0 reduced
18 sold out
net sold ≈ $20.2m (-4.1m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2020 | 19 |
| Q1 2021 | 18 |
| Q2 2021 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2021 | 8 | 9 |
| Q2 2021 | 0 | 18 |
Biggest buyers
| None |
Biggest sellers
| TANG CAPITAL MANAGEMENT LLC | Sold out | -1.0m |
| ACUTA CAPITAL PARTNERS, LLC | Sold out | -520.0k |
| PUTNAM INVESTMENTS LLC | Sold out | -500.0k |
| RTW INVESTMENTS, LP | Sold out | -500.0k |
| CITADEL ADVISORS LLC | Sold out | -425.1k |
| PERCEPTIVE ADVISORS LLC | Sold out | -300.0k |
| Affinity Asset Advisors, LLC | Sold out | -218.0k |
| Altium Capital Management LLC | Sold out | -215.2k |
| EcoR1 Capital, LLC | Sold out | -150.0k |
| Athanor Capital, LP | Sold out | -78.0k |
Holders, Q2 2021
| Manager | Shares | Change |
|---|